Anybody up for a little microcap biotech?
Heh heh, probably not, I'm not even sure if
I will try to trade this one, since I already
own a chunk for holding, and it is usually
not tradable.
Anyway, the company is Biotransplant, BTRN
here is the news item
biz.yahoo.com
(snip)Further analysis indicated that six of 11 evaluable patients achieved a complete remission and two of 11 a partial remission, despite having advanced cancers that did not respond to other treatments. Seven of the 15 patients who received the new therapy are alive and progression free at a median period of 169 days (range, 27 to 475 days) following BMT.
Dr. Sykes and colleagues separately reported an evaluation of five patients that received the new BMT therapy after experiencing a relapse in their blood cell cancers. In four of these five patients, chimeric immune systems were established without the development of severe GvHD. These patients showed potent anti-tumor activity against the cancerous blood cells, with four complete remissions and one partial remission in this subgroup, and retained the ability to mount immune responses against other foreign elements.
(snip)
Be careful with this one, I watched it a long time and have
1000 shares which I bought when it was below book value! It
is still obviously a bargain, hell, probably a bargain at $5,
but every time I think I see a sure thing, it backfires.
A lot of these microcap biotechs have retreated to one or two
times book over the last few years. I suppose it is very
reasonable for things with high burn rates to trade near book
if they have no prospects, but as far as I can tell, BTRN
has real prospects. I over-rely on the biotech freaks here on
SI, but I've been studying lately, Graft v Host disease is
obviously a very important area to be doing cutting edge
science...BTRN is right there in the thick of things.
Obviously one to watch, a very good choice to own long
term, and maybe even tradable today for a change.
--MM |
